EC Nutrition

Case Report Volume 14 Issue 11 - 2019

Prolonged Icterus in the Course of Galactosemia Presentation of a Case

Ursula Hilaria Carrillo Estrada1*, Rosa María García Nieblas2, Nancy Dueñas Gobel1, Silvia Clariris Roche Case1, Geleny Marìa Alonso Sánchez1, Cecilia Margarita Castañeda Garcìa2, Georgina Marìa Zayas Torriente3, Annie Sanabria Villar1 and Dainet Abreu Soto3

1Borras Marfan University Pediatric Hospital, Cuba

2Manuel Fajardo Faculty of Medical Sciences, Cuba

3National Institute of Hygiene Epidemiology and Microbiology, Cuba
*Corresponding Author: Ursula Hilaria Carrillo Estrada, Borras Marfan University Pediatric Hospital, Cuba.
Received: December 07, 2018; Published: October 24, 2019



Male patient of 7 months admitted to the Pediatric Service of the Institute of Gastroenterology, for yellowing of the skin and mu- cous membranes, diarrhea and weight loss, as a result of a third pregnancy of parents without a degree of consanguinity, delivery at term, physiological, weight and size appropriate for gestational age, APGAR 9/9; He presented prolonged icterus without apparent complications. A history of multiple admissions due to complicated diarrheal diseases. Among the clinical signs of interest, the yellowish color of the skin and mucous membranes is remarkable, as well as a marked decrease in the panniculus adipose, the globular abdomen and the hepatomegaly of 5 cm. of fine edges. In the interrogation, made to the mother, it was known that the symptoms began with the introduction of breastfeeding, characterized by vomiting and diar- rhea. Metabolic disease was suspected and it was consulted with the Hospital Pedro Borras Nutrition, indicating a urine test in which galactose appears, later it was indicated, quantification of galactose in blood that showed values ​​ of 20 mg/dl and enzymatic activity whose values ​​ were 4.3 u/gHb, conclusive of galactosemia. Dietary treatment was indicated, excluding dairy products and their derivatives, appreciating clinical, anthropometric and bio- chemical improvements. In the follow-up controls, elevated levels of pyruvic transaminase (30 IU) were found, which motivates their re-entry, detecting a transgression in the diet. Adjustment of the daily intake is made, with a satisfactory evolution.

keywords: Galactosemia; Enzymatic Activity; Dietary Therapy Treatment

  1. Segal S. “Galactosemia today. The enigma and the challenge In her”. Metabolic Disease 21 (1998): 455-471.
  2. Bosch A., et al. “Living with classical galactosemia”. Paediatrics 5 (2004): 423-428.
  3. 1st Meeting of Experts on Inborn Errors of Metabolism. Paediatrics 42 (1995): 107 -109.
  4. Berry GT., et al. “Disorders of galactose Metabolism”. In: Fernandez J, Saudurbray JM, Vanden Bergue G, Waltre JH, eds. Inborn Metabolic Diseases: Diagnosis and Treatment. 4th Edition New York, NY: Springer (2006): Chapter 7.
  5. Nancy D Leslie. “Insights into the pathogenesis of galactosemia”. Annual Review of Nutrition 23 (2003): 59-80.
  6. Ibarra B., et al. “Los Angeles variant of galactose-1-phosphate uridil transferase (EC2.7.7.12) in a Mexican family”. Human Genetics 1 (1979): 121-124.
  7. Andersen M., et al. “Transferase-deficiency galactosemia: evidence for the lack of transferase protein in galactosemic red cells”. Archives of Biochemistry and Biophysics 1 (1983): 326-331.
  8. Hammersen G., et al. “Rennes-like variant of galactosemia: clinical and biochemical studies”. The Journal of Pediatrics 1 (1975): 50-57.
  9. Hill HZ and Puck TT. “Detection of inborn errors of metabolism: galactosemia”. Science4078 (1973): 1136-1139.
  10. Mason HH and Turner ME. “Chronic galactosemia: report of case with studies on carbohydrates”. The American Journal of Diseases of Children 50 (1935): 359-374.
  11. Berry GT., et al. “Disorders of Galactose Metabolism”. In. (2006).
  12. Cornejo V and Raiman E. “Diet therapy in some inborn errors of metabolism”. Revista Chilena de Nutricion1 (2004): 18-24.
  13. M Ruiz Pons., et al. Editions Ergon. Spanish Society of Inborn Errors of Metabolism. Nutritional treatment of inborn errors of metabolism (2004).
  14. Alcaraz Sanz Ma D., et al. “Early detection of congenital metabolopathies in neonatology, August (2007).
  15. Enf. Met. Produced by defective enzymes (2009).
  16. Medline Plus. Galactosemia ADAM (2009).
  17. Monograph: Galactosemia (ICD-10: E 74.2) (2004).
  18. A Baldellou Vázquez. “Present and future in the treatment of congenital errors of metabolism”. Comprehensive Pediatrics 6.8 (2002): 721-731.
  19. “Galactosemia”. Archives of Pediatrics 1.6 (2006).
  20. “Galactosemia”. Argentine Archives of Pediatrics 107.5 (2009).
  21. Alleyne (Panama). Galactosemia 58th Session of the Regional Committee. Washington DC; USA (2006): 25.
  22. Molecular Pathology- University of León. Academic year 2009/2010. Enzymatic anomalies of galactose metabolism.
  23. Bolisteri W F., et al. “Genetic cholestasis”. Journal of Medical Genetics 42 (2005).
  24. Jaeken J and Matthijs G. “Introduction to congenital galactose defects”. Book of Presentations (Zaragoza) 1-414 (2007): 96-102.
  25. Gaw TO., et al. The laboratory in the clinical diagnosis of galactose (2005).
  26. Principles of Biochemistry. Galactosemia Definition. Type of inheritance Pathophysiology Diagnosis. Treatment. Edit. March (2005).
  27. Bernard O., et al. “Diagnosis of neonatal cholestasis”. Journal of Pediatric Gastroenterology and Nutrition 40.33 (2005): 90- 93.
  28. Bruinjnzeel-Koomen C., et al. “Food intolerance to galactose”. Medical Journal 81 (2005): 167-73.5
  29. “Metabolic alterations in galactosemia”. Mc Graw-Hill Interamericana, 2nd Edition (2005).
  30. , et al. “Principles of Biochemistry Third Edition”. Worth Publication USES. Galactosemia enzymatic defects. Metabolic consequences (2005).
  31. Sandubry JM., et al. “Clinical approach to treatable inborn metabolic diseases: an introduction”. Journal of Inherited Metabolic Disease2-3 (2006): 261-274.
  32. Galactosemia- A Medical Dictionary, Bibliography. Icon Health Publications (2004): 156.
  33. M F Rodríguez Reynoso and F Sánchez Ruiz.” Spanish Society of Gastroenterology, Hepatology and Pediatric Nutrition, Edition. 1ª. Intolerance to carbohydrates, galactosemia, fructosemia (2004).
  34. “ND Insights into the pathogenesis of galactosemia”. Annual Review of Nutrition 23 (2003): 59-50.
  35. Gallo A., et al. “Reference values of galactose-1-phosphate in red blood cells”. ISSN Scientific Journal 4 (2002): 47-36.
  36. Murillo M. “Determination of the enzymatic activity of erythrocyte galactokinase”. Journal of the Colombian Association of Biological Sciences 19 (2007): 140-160.
  37. Prevalence Anales de Pediatría Journal 62 (2005): 245-63.
  38. Gutiérrez E., et al. “Galactosemia: Diagnosis of 5 cases with transferase deficit”. Cuban Journal of Pediatrics2 (2001): 39.
  39. Carrillo U., et al. “Galactosemia: Early diagnosis by enzymatic study”. Cuban Journal of Pediatrics 3 (2003).

Ursula Hilaria Carrillo Estrada., et al., “Prolonged Icterus in the Course of Galactosemia Presentation of a Case”. EC Nutrition  14.11 (2019): 96-100.